NCT01288196 - A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Healthy

Interventions

DRUG

Placebo IV

A single 30-minute IV infusion of placebo

DRUG

CNTO 6785 1 mg/kg IV

A single 30-minute IV infusion of CNTO 6785 1 mg/kg

DRUG

CNTO 6785 3 mg/kg IV

A single 30-minute IV infusion of CNTO 6785 3 mg/kg

DRUG

CNTO 6785 10 mg/kg IV

A single 30-minute IV infusion of CNTO 6785 10 mg/kg

DRUG

CNTO 6785 SC

A single SC dose of CNTO 6785 (3 mg/kg) administered in up to 3 SC injections

DRUG

Placebo SC

A single SC dose of placebo administered in up to 3 SC injections

Trial Locations (1)

Merksem